Free Trial
→ This stock has 30 days of quiet left (From Behind the Markets) (Ad)tc pixel
NASDAQ:TAOX

Synaptogenix 11/14/2025 Earnings Report

Synaptogenix logo
$4.53 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$4.62 +0.09 (+2.08%)
As of 05/22/2026 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Synaptogenix EPS Results

Actual EPS
-$1.56
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Synaptogenix Revenue Results

Actual Revenue
$2.41 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Synaptogenix Announcement Details

Quarter
Date
11/14/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Synaptogenix Earnings Headlines

Synaptogenix (NASDAQ:TAOX) Rating Increased to Hold at Wall Street Zen
May 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30780792
TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation
November 18, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-and-yuma-asset-management-to-host-livestream-on-x-bittensor-tao-and-deai-innovation-302618425.html
One page of the SpaceX S-1 will move this stock overnight
When SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including power consumption for 1 million GPUs, a cost that rivals entire cities. That disclosure will name the supplier. One small, publicly traded power infrastructure company sits at the center of this - carrying a $1.5 billion backlog and priced like a utility. Dylan Jovine has the full breakdown.tc pixel
 |  Behind the Markets (Ad)
Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys
November 11, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tradr-set-to-debut-etfs-targeting-bloom-energy-celestica-nano-nuclear-and-synopsys-302611818.html
TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds
November 4, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-announces-initial-750-000-investment-in-yuma-asset-managements-subnet-funds-302603960.html
TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency
October 20, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-raises-bittensor-tao-holdings-to-over-54-000-tokens-largest-publicly-traded-holder-of-top-decentralized-ai-cryptocurrency-302589032.html
See More Synaptogenix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Synaptogenix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Synaptogenix and other key companies, straight to your email.

About Synaptogenix

Synaptogenix (NASDAQ:TAOX) operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

View Synaptogenix Profile
Earnings Tools